Literature DB >> 1455569

Periurethral colonization and urinary leukocytes as markers for bacteriuria in children with neurogenic bladder.

T A Schlager1, S A Dilks, J A Lohr, G F Hayden, J A Kopco, J W Hendley.   

Abstract

Bacteriuria and associated renal damage is common in children with a neurogenic bladder, but the pathogenesis of urinary tract infection (UTI) is undefined. We examined the association between periurethral bacterial colonization and the presence of urinary leukocytes in 76 catheter urine specimens from children with neurogenic bladders. Although all the children were asymptomatic, 38/76 (50%) of the urine cultures were positive. Periurethral colonization was significantly more common with positive than with negative urine cultures, suggesting a pathogenetic role for periurethral bacteria in infection of the neurogenic bladder. Urinary leukocytes were present in 24/38 (63%) with positive cultures, as against none (0/38) of those with negative urine cultures, and their presence represents a host response to bladder bacteriuria.

Entities:  

Mesh:

Year:  1992        PMID: 1455569     DOI: 10.1007/bf00922749

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  Asymptomatic infections of the urinary tract.

Authors:  E H KASS
Journal:  Trans Assoc Am Physicians       Date:  1956

2.  Genetic relationships among Escherichia coli isolates causing urinary tract infections in humans and animals.

Authors:  T S Whittam; M L Wolfe; R A Wilson
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

Review 3.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

4.  Urinary tract infection in children with myelomeningocele.

Authors:  D G Cooper
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

5.  Further evaluation of the Griess test to detect significant bacteriuria. II.

Authors:  A W Czerwinski; R G Wilkerson; J A Merrill; B Braden; J P Colmore
Journal:  Am J Obstet Gynecol       Date:  1971-07-01       Impact factor: 8.661

6.  Association of bacteriuria and pyuria during intermittent catheterization after spinal cord injury.

Authors:  R U Anderson; S T Hsieh-Ma
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

7.  The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections.

Authors:  T A Stamey; C C Sexton
Journal:  J Urol       Date:  1975-02       Impact factor: 7.450

8.  The periurethral aerobic flora in girls highly susceptible to urinary infections.

Authors:  I Bollgren; J Winberg
Journal:  Acta Paediatr Scand       Date:  1976-01

9.  Long-term renal risk factors in children with meningomyelocele.

Authors:  A S Brem; D Martin; J Callaghan; J Maynard
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

10.  Incidence of urinary tract complications with myelomeningocele.

Authors:  A S Cass; M Luxenberg; C F Johnson; P Gleich
Journal:  Urology       Date:  1985-04       Impact factor: 2.649

View more
  3 in total

1.  Predictive ability of NGAL in identifying urinary tract infection in children with neurogenic bladders.

Authors:  Catherine S Forster; Elizabeth Jackson; Qing Ma; Michael Bennett; Samir S Shah; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2018-03-12       Impact factor: 3.714

2.  Symptom- and urinalysis-based approach to diagnosing urinary tract infections in children with neuropathic bladders.

Authors:  Catherine S Forster; Jichuan Wang
Journal:  Pediatr Nephrol       Date:  2020-01-09       Impact factor: 3.714

3.  E. coli virulence factors in children with neurogenic bladder associated with bacteriuria.

Authors:  Eliana B M Guidoni; Vanessa A Dalpra; Patrícia Maria Figueiredo; Domingos da Silva Leite; Lycia Mara J Mímica; Tomomasa Yano; Jesus E Blanco; Julio Toporovski
Journal:  Pediatr Nephrol       Date:  2005-12-31       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.